Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 507,600 | 339,354 | 265,469 | 173,998 | 204,554 |
| Marketable Securities | 13,200 | 12,683 | 12,718 | 12,711 | 11,799 |
| Receivables | 305,000 | 314,475 | 297,171 | 273,305 | 267,117 |
| Inventories | 473,100 | 481,559 | 490,701 | 521,322 | 490,601 |
| Income taxes - deferred | 111,000 | 106,311 | 105,199 | 113,252 | 113,633 |
| TOTAL | $1,458,400 | $1,323,265 | $1,245,359 | $1,163,627 | $1,173,776 |
| Non-Current Assets | |||||
| PPE Net | 658,500 | 660,549 | 672,670 | 684,507 | 688,185 |
| Investments And Advances | 80,600 | 73,204 | 71,488 | 70,512 | 68,034 |
| Intangibles | 1,428,100 | 1,411,976 | 1,440,373 | 1,460,225 | 1,480,146 |
| Other Non-Current Assets | 52,300 | 76,360 | 59,897 | 60,773 | 61,886 |
| TOTAL | $2,219,500 | $2,222,089 | $2,244,428 | $2,276,017 | $2,298,251 |
| Total Assets | $3,677,900 | $3,545,354 | $3,489,787 | $3,439,644 | $3,472,027 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 53,200 | 3,217 | 2,949 | 2,851 | 6,241 |
| Accounts payable and accrued liabilities | 381,300 | 353,745 | 382,050 | 376,545 | 398,154 |
| TOTAL | $482,000 | $398,100 | $424,867 | $435,721 | $444,927 |
| Non-Current Liabilities | |||||
| Long Term Debt | 824,700 | 824,609 | 824,540 | 824,473 | 899,408 |
| Deferred Revenues | 16,100 | 16,281 | 14,592 | 17,610 | 21,754 |
| aiOther Non-Current Liabilities | 58,200 | 56,831 | 58,993 | 60,492 | 59,952 |
| TOTAL | $1,087,300 | $1,096,971 | $1,094,486 | $1,100,556 | $1,177,635 |
| Total Liabilities | $1,569,300 | $1,495,071 | $1,519,353 | $1,536,277 | $1,622,562 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 104,627 | 104,608 | 104,465 | 104,441 | 103,658 |
| Common Shares | 400 | 376 | 375 | 375 | 373 |
| Retained earnings | 1,418,100 | 1,361,730 | 1,290,669 | 1,230,366 | 1,179,737 |
| Other shareholders' equity | -2,800 | -232 | 1,125 | 1,492 | 2,616 |
| TOTAL | $2,108,600 | $2,050,283 | $1,970,434 | $1,903,367 | $1,849,465 |
| Total Liabilities And Equity | $3,677,900 | $3,545,354 | $3,489,787 | $3,439,644 | $3,472,027 |